RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
  Cataract
  Cornea
  Retina
   ARMD
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
ARMD Channel

subscribe to ARMD newsletter
Latest Research : Ophthalmology : Retina : ARMD

   EMAIL   |   PRINT
High Body Mass Index Increase the Genetic Risk of AMD

Jul 1, 2006 - 5:41:00 PM , Reviewed by: Priya Saxena
“There is no question that genetic factors play an important role in this disease. However, individuals with the risk genotype may be more motivated to adhere to healthy lifestyles such as not smoking, maintaining a normal weight, getting exercise, eating an antioxidant rich diet, as well as fish, and getting exercise.”

 
[RxPG] Current cigarette smoking was associated with a fivefold increased risk and high BMI (30 or higher) was associated with a twofold higher risk of AMD. The homozygous risk genotype (CC) plus smoking conferred a tenfold higher risk of AMD, compared with non-smokers with the non-risk (TT) genotype, while the risk genotype plus higher BMI increased risk of AMD almost sixfold. Gene plus environment risk scores provided an area under the receiver operating characteristic (ROC) curve of 0.70-0.75. The attributable risks for the combination of genes and environment were 69% to 73%.

Subjects in this study were Caucasians who had either advanced AMD (574 people) or no evidence of AMD (280 individuals), based on ocular examination and ocular photographs. DNA samples were obtained from the genetic repository of the Age-Related Eye Disease Study, a National Institutes of Health (NIH) clinical trial for which Johanna M. Seddon, M.D., director of the Epidemiology Unit at MEEI and an associate professor of ophthalmology at Harvard Medical School, was clinic director at MEEI. DNA samples were genotyped at the Broad Institute Center for Genotyping and Analysis, Boston, Mass. and statistical analyses were done in the Epidemiology Unit at MEEI.

“These findings convey an important message. Although we cannot change our genotype, we can alter or modify our risk of getting AMD by controlling our weight and not smoking,” said Dr. Seddon. “There is no question that genetic factors play an important role in this disease. However, individuals with the risk genotype may be more motivated to adhere to healthy lifestyles such as not smoking, maintaining a normal weight, getting exercise, eating an antioxidant rich diet, as well as fish, and getting exercise.”

AMD is the leading cause of irreversible visual impairment and blindness among persons aged 60 and older. With the elderly population steadily growing, the burden related to this loss of visual function will increase. Limited treatment options exist for the late stages of the disease and prevention remains a promising approach for addressing this public health concern.



Publication: These findings are published online now in the journal Human Heredity.
On the web: www.meei.harvard.edu 

Advertise in this space for $10 per month. Contact us today.


Related ARMD News
Deficiency of the Dicer enzyme in retinal cells linked to age-related macular degeneration
Quit smoking to save your eyes
Post Menopausal Hormones - reduces risk of macular degeneration
Higher fish consumption have a reduced risk of advanced age-related macular degeneration
HTRA1 gene linked to aggressive 'wet' age-related macular degeneration
Yellow plant pigments lutein and zeaxanthin reduce risk of age-related macular degeneration
Hormone Therapy Does Not Affect Age-Related Vision Loss
Eating Fish Protects Against Macular Degeneration
Research Highlights Risk Factors For Age-Related Vision Loss
FDA approves ranibizumab for the treatment of wet age-related macular degeneration

Subscribe to ARMD Newsletter

Enter your email address:


 Additional information about the news article
Lead author Dr. Seddon and her colleagues have studied the genetics of AMD since 1989, and previously reported that the heritability of AMD is high (46% to 71%) in a cohort of WWII twins and that both genetic and environmental factors are involved (Arch Ophthalmol 2005), and that there is a familial aggregation (Am J Ophthalmol, 1997), as well as linkage of AMD to several chromosomes (Am J Hum Genetics 2003). A decade ago they reported the increased risk of AMD with cigarette smoking (JAMA 1996). They also reported the increased risk associated with higher body mass index or obesity (Arch Ophthalmol 2003). This article in Human Heredity is the first to combine both of these behavioral factors with genetic risk. Dr. Seddon and her colleagues have also found other cardiovascular risk factors to be related to AMD, including an increased risk with elevated C-reactive protein (JAMA 2004) and a reduced risk associated with fish and omega-3 fatty acid intake (Arch Ophthalmol 2001, 2003, 2006).

This most recent research was supported by the National Eye Institute, Bethesda, Md.; the Foundation Fighting Blindness Inc, Owing Mills, Md.; the Massachusetts Lions Eye Research Fund Inc., Northboro, Mass.; a grant from the National Center for Research Resources to the Broad Institute Center for Genotyping and Analysis, Cambridge, Mass.; and the Epidemiology Unit Genetics of AMD Research Fund, Massachusetts Eye and Ear Infirmary, Boston, Mass.

Founded in 1824, Massachusetts Eye and Ear Infirmary (MEEI) is an independent specialty hospital providing patient care for disorders of the eye, ear, nose, throat, head and neck. MEEI is an international leader in Ophthalmology and Otolaryngology research and a teaching partner of Harvard Medical School.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)